ALVO OAKTREE ACQUISITION CORP II

Alvotech S.A. Annual General Meeting to be held June 7, 2024

Alvotech S.A. Annual General Meeting to be held June 7, 2024

The Annual General Meeting of Alvotech S.A. will be held on Friday June 7, 2024, at 09.00 a.m. CEST at the premises of Arendt & Medernach S.A. at 41A, Avenue John F. Kennedy L-1855 Luxembourg, Grand Duchy of Luxembourg.

Reference is made to the attached document with regard to the final agenda.

Meeting materials and all further information about the Annual General Meeting is available on the Alvotech website: .

CONTACTS



Alvotech Investor Relations

Benedikt Stefansson, Senior Director

Attachment



EN
15/05/2024

Underlying

ALVOOAKTREE ACQUISITION CORP II

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on OAKTREE ACQUISITION CORP II

 PRESS RELEASE
Free
ALVO OAKTREE ACQUISI...

Alvotech Announces Webcast to Report Financial Results for the First H...

Alvotech Announces Webcast to Report Financial Results for the First Half of 2025 on August 14, 2025, at 8:00 am EDT REYKJAVIK, ICELAND (August 6, 2025) – Alvotech (NASDAQ: ALVO), a global biotech company specialized in the development and manufacture of biosimilar medicines for patients worldwide, announced today that it will release financial results for the first half of the year ended June 30, 2025, after U.S. markets close on Wednesday, August 13, 2025.  Alvotech will also conduct a conference call to present the financial results and recent business highlights on Thursday August 14, ...

August 6, 2025 1 EN
 PRESS RELEASE
Free
ALVO OAKTREE ACQUISI...

Alvotech kynnir uppgjör fyrri helmings ársins 2025 þann 14. ágúst nk. ...

Alvotech kynnir uppgjör fyrri helmings ársins 2025 þann 14. ágúst nk. kl. 12 á hádegi REYKJAVÍK (6. ágúst 2025) Alvotech (NASDAQ: ALVO) mun senda út tilkynningu með uppgjöri fyrir fyrri helming ársins 2025 eftir lokun markaða í Bandaríkjunum, miðvikudaginn 13. ágúst nk. Fundur til kynningar á uppgjörinu verður sendur út í beinu streymi og hefst hann kl. 12 á hádegi, fimmtudaginn 14. ágúst nk. Streymi af uppgjörsfundinum, sem fer fram á ensku, verður aðgengilegt á fjárfestasíðu Alvotech, , á slóðinni . Þar verður einnig hægt að finna upptöku af fundinum eftir að honum er lokið, sem aðgengil...

August 6, 2025 1 EN
 PRESS RELEASE
Free
ALVO OAKTREE ACQUISI...

Inbjudan til Alvotech presentation av bokslutskommunikén och rapporten...

Inbjudan til Alvotech presentation av bokslutskommunikén och rapporten för första halvåret 2025 REYKJAVIK, ISLAND (6 AUGUSTI, 2025) – Alvotech (NASDAQ:ALVO SDB), ett globalt biofarmaceutiskt företag som specialiserar sig på utveckling och tillverkning av biosimilära läkemedel för patienter över hela världen, publicerar bokslutskommunikén för första halvåret som slutade den 30 juni 2025 den 13 augusti 2025 efter att de amerikanska marknaderna stängt. Resultaten presenteras i en webcast och telefonkonferens klockan 14:00 CET (8:00 AM EDT) den 14 augusti 2025. Presentationen hålls på engelsk...

August 6, 2025 1 EN
 PRESS RELEASE
Free
ALVO OAKTREE ACQUISI...

Alvotech Announces Webcast to Report Financial Results for the First H...

Alvotech Announces Webcast to Report Financial Results for the First Half of 2025 on August 14, 2025, at 8:00 am EDT REYKJAVIK, Iceland, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specialized in the development and manufacture of biosimilar medicines for patients worldwide, announced today that it will release financial results for the first half of the year ended June 30, 2025, after U.S. markets close on Wednesday, August 13, 2025. Alvotech will also conduct a conference call to present the financial results and recent business highlights on Thu...

August 6, 2025 1 EN
 PRESS RELEASE
Free
ALVO OAKTREE ACQUISI...

Alvotech skipar Lindu Jónsdóttur í stöðu framkvæmdastjóra fjármálasvið...

Alvotech skipar Lindu Jónsdóttur í stöðu framkvæmdastjóra fjármálasviðs REYKJAVÍK (10. JÚLÍ 2025) - Alvotech (NASDAQ: ALVO) hefur skipað Lindu Jónsdóttur í stöðu framkvæmdastjóra fjármálasviðs. Linda er reyndur alþjóðlegur stjórnandi á sviði rekstrar og fjármála. Hún hefur áður gegnt leiðtogastöðum fyrirtækja á sviði iðnaðar, fjármála, flutningastarfsemi og heilbrigðismála. Joel Morales sem verið hefur framkvæmdastjóri fjármálasviðs Alvotech frá árinu 2020 hefur ákveðið að láta af störfum til þess að geta varið meiri tíma með fjölskyldunni og á heimaslóðum í Bandaríkjunum. Hann verður félag...

July 10, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch